Garcia–Barreras S, et al. – An analysis was designed to evaluate oncologic and functional outcomes of partial gland ablation (PGA) compared with robot–assisted radical prostatectomy (RARP) for patients with low–and intermediate–risk prostate cancer. Partial gland ablation proposed good oncological control with fewer adverse effects requiring more additional treatments for selected patients with organ–confined prostate cancer. In addition, potency and continence appear to be better preserved with PGA.